LifeMD, Inc. (LFMD)
LFMD moved a median of -0.08% 30 minutes after news, and -0.17% by the close. How LFMD actually reacts to news — the realized, point-in-time move the market made, measured across 1,048 labeled events over the last three years with zero look-ahead.
LFMD’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 46% | 1,041 |
| 30-min | -0.08% | 45% | 1,047 |
| 60-min | -0.09% | 45% | 1,047 |
| to close | -0.17% | 45% | 1,044 |
| Middle 50% of LFMD reactions | -0.79% to +0.49% |
|---|---|
| Median reaction (30-min) | -0.08% |
| Measured reactions | 1,048 |
Half of all LifeMD, Inc. news events land between -0.79% and +0.49% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How LFMD reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades | 10 | +0.92% | 70% | +1.38% |
| Coverage initiations | 14 | -0.65% | 43% | +0.53% |
| Rating reiterations | 61 | -0.19% | 41% | +0.38% |
| Price-target raises | 10 | +0.46% | 60% | +0.48% |
| Price-target cuts | 13 | +0.20% | 54% | +0.76% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. 1 further class was observed with fewer than 10 measured events and is not published. See how LFMD ranks against every other measured name →
That’s how LFMD usually reacts — get an email when it moves on news →Email me when LFMD moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to LFMD's baseline. Nothing else.
Recent LFMD events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock | Press release | GlobeNewswire | -2.13% | -7.01% | |
| LifeMD Reports Second Quarter 2026 Results | Press release | GlobeNewswire | +2.48% | +5.59% | |
| UPDATE - LifeMD Reports Second Quarter 2026 Results | Press release | GlobeNewswire | +2.48% | +5.59% | |
| LifeMD to Report Second Quarter 2026 Financial Results on August 5 | Press release | GlobeNewswire | +0.67% | +3.48% | |
| LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock | Press release | GlobeNewswire | +2.34% | +6.31% | |
| LifeMD Announces Exclusive Collaboration to Launch Direct-to-Patient Self-Pay Program for XYOSTED® (testosterone enanthate) Injection | Press release | GlobeNewswire | +0.32% | -8.69% | |
| LifeMD Appoints Umesh Sripad as Chief Technology Officer | Press release | GlobeNewswire | -0.47% | +8.43% | |
| LifeMD to Participate in Upcoming Investor Conferences | Press release | GlobeNewswire | +1.83% | -1.14% | |
| LifeMD Reports First Quarter 2026 Results | Press release | GlobeNewswire | -1.47% | -5.67% | |
| LifeMD to Report First Quarter 2026 Financial Results on May 6 | Press release | GlobeNewswire | +0.87% | -0.22% | |
| LifeMD® Now Offering Eli Lilly and Company’s Foundayo™ (orforglipron), a New GLP-1 Pill for Weight Management | Press release | GlobeNewswire | +4.62% | -0.86% | |
| LifeMD Offers Novo Nordisk's Industry-First Wegovy® Telehealth Subscription Program | Press release | GlobeNewswire | -1.64% | -1.37% | |
| LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock | Press release | GlobeNewswire | +0.51% | -0.76% | |
| Form 8-K LifeMD, Inc. For: Mar 16 | SEC filing · Form 8-K | SEC EDGAR | +2.75% | +2.25% | |
| LifeMD Appoints Veteran Healthcare Finance Executive as Chief Financial Officer and Expands Leadership Team | Press release | GlobeNewswire | +7.60% | +1.38% | |
| Form 10-K LifeMD, Inc. For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +14.71% | +1.50% | |
| Form 8-K LifeMD, Inc. For: Mar 09 | SEC filing · Form 8-K | SEC EDGAR | +4.57% | +11.71% | |
| LifeMD Reports Fourth Quarter and Full Year 2025 Results | Press release | GlobeNewswire | +4.57% | +11.71% | |
| LifeMD to Participate in Two Investor Conferences During March | Press release | GlobeNewswire | +0.68% | +5.76% | |
| LifeMD to Report Fourth Quarter 2025 Financial Results on March 9 | Press release | GlobeNewswire | -1.79% | -5.71% | |
| Form 8-K LifeMD, Inc. For: Jan 02 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +6.83% | |
| LifeMD Announces Closing of $50 Million Revolving Credit Facility with Citizens Bank, N.A. | Press release | GlobeNewswire | +0.00% | +6.83% | |
| LifeMD Expands Collaboration with Novo Nordisk as Recognized Telehealth Partner Offering Newly Approved Wegovy® Pill | Press release | GlobeNewswire | +4.13% | +7.71% | |
| LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock | Press release | GlobeNewswire | -4.09% | -10.49% | |
| LifeMD Recognized by the 2025 Deloitte Technology Fast 500™ and by TIME’s America’s Growth Leaders of 2026 | Press release | GlobeNewswire | +1.41% | +1.53% | |
| Form 10-Q LifeMD, Inc. For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | +8.57% | +16.86% | |
| Form 8-K LifeMD, Inc. For: Nov 17 | SEC filing · Form 8-K | SEC EDGAR | +8.57% | +16.86% | |
| LifeMD Reports Third Quarter 2025 Results | Press release | GlobeNewswire | +8.57% | +16.86% | |
| LifeMD® to Offer Market-Leading Pricing for GLP-1 Medications Wegovy® and Ozempic® in Continued Collaboration with Novo Nordisk | Press release | GlobeNewswire | -3.06% | -3.47% | |
| Lifshitz Law PLLC Announces Investigations of LifeMD, Inc. (NASDAQ: LFMD), Savara Inc. (NASDAQ: SVRA), Lantheus Holdings, Inc. (NASDAQ: LNTH), and Fly-E Group, Inc. (NASDAQ: FLYE) | Press release | ACCESS Newswire | -0.21% | — | |
| Form NT 10-Q LifeMD, Inc. For: Sep 30 | SEC filing · Form NT | SEC EDGAR | -3.40% | — | |
| LifeMD to Participate in the BTIG Digital Health Forum | Press release | GlobeNewswire | -1.12% | -4.47% | |
| Form 8-K LifeMD, Inc. For: Nov 05 | SEC filing · Form 8-K | SEC EDGAR | -0.90% | -5.22% | |
| LifeMD Reschedules Third Quarter 2025 Earnings Release and Conference Call to November 17 | Press release | GlobeNewswire | -0.90% | -5.22% | |
| Form 8-K LifeMD, Inc. For: Nov 04 | SEC filing · Form 8-K | SEC EDGAR | -0.07% | -0.28% | |
| LifeMD Divests Majority Interest in WorkSimpli Software, Positioning Company as a Pure-Play Virtual Care and Pharmacy Platform | Press release | GlobeNewswire | -0.36% | -3.56% | |
| LifeMD, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - LFMD | Press release | PR Newswire | +0.16% | -3.31% | |
| LifeMD, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – LFMD | Press release | GlobeNewswire | +0.16% | -3.31% | |
| LifeMD to Report Third Quarter 2025 Financial Results on November 6 | Press release | GlobeNewswire | -0.48% | +0.48% | |
| LifeMD, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - LFMD | Press release | PR Newswire | -0.48% | +0.48% | |
| LifeMD Names Dr. Tara Scott as Ambassador and Clinical Advisor for its Women’s Health Program | Press release | GlobeNewswire | +0.00% | +0.82% | |
| LifeMD, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - LFMD | Press release | PR Newswire | +0.32% | +0.65% | |
| LifeMD, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - LFMD | Press release | PR Newswire | -0.28% | +4.79% | |
| LifeMD, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - LFMD | Press release | PR Newswire | -0.22% | -4.47% | |
| LifeMD, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - LFMD | Press release | PR Newswire | +0.00% | +1.76% | |
| LifeMD Offers Ozempic® at $499 Per Month through Collaboration with Novo Nordisk | Press release | GlobeNewswire | +4.02% | +3.04% | |
| LifeMD to Participate in the ROTH 4th Annual Healthcare Opportunities Conference | Press release | GlobeNewswire | +1.13% | +3.54% | |
| LifeMD, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – LFMD | Press release | Business Wire | +0.08% | +0.87% | |
| LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock | Press release | GlobeNewswire | +0.94% | +0.47% | |
| LifeMD Expands Pharmacy Services with Non-Sterile Compounding to Deliver Personalized, Cost-Efficient Therapies at Scale | Press release | GlobeNewswire | +1.06% | +5.07% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the LFMD section they belong to.
Where else LFMD is measured.
LFMD earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is LifeMD, Inc.'s median reaction calculated?
Every labeled LFMD news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 1,048 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 45% of LFMD's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does LFMD's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.